Stereospecific induction of nuclear factor-κB activation by isochamaejasmin

Molecular Pharmacology

Volumn 68, Issue 6, 2005, Pages 1534-1542

  Tian, Qinghai ^b   Li, Jing ^c   Xie, Xin ^a   Sun, Meiling ^a   Sang, Hairong ^c   Zhou, Caihong ^a   An, Tianying ^a   Hu, Lihong ^a   Ye, Richard D ^c   Wang, Ming Wei ^a,d  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF ILLINOIS   (United States)

^d National Center for Drug Screening   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIFLAVONOID; CHAMAEJASMIN B; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOCHAMAEJASMIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEOCHAMAEJASMIN A; NEOCHAMAEJASMIN B; NPLC 0168; NPLC 0169; NPLC 0548; NPLC 0549; PROTEIN KINASE C; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHINESE HERB; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HELA CELL; HUMAN; HUMAN CELL; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; STELLERA CHAMAEJASME; STEREOISOMERISM; STEREOSPECIFICITY;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; BIFLAVONOIDS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTEIN KINASES; STEREOISOMERISM; TRANSFECTION;

EID: 27844448130     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.014720     Document Type: Article

References (35)

1. Arlt A and Schafer H (2002) NFB-dependent chemoresistance in solid tumors. Int J Clin Pharmacol Ther 40:336-347.
2. Baek SH, Seo JK, Chae CB, Suh PG, and Ryu SH (1996) Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 271:8170-8175.
3. Caramori G, Adcock IM, and Ito K (2004) Anti-inflammatory inhibitors of IκB kinase in asthma and COPD. Curr Opin Investig Drugs 5:1141-1147.
4. Chiang N, Fierro IM, Gronert K, and Serhan CN (2000) Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191:1197-1208.
5. Gong SL (1982) Langdu, in Annals of Traditional Chinese Medicine (Institute of Materia Medica, Chinese Academy of Medical Sciences ed) vol 2, pp 12-17, Peoples Health Press, Beijing, China.
6. Guo YB (1986) Effects of Langdu on 250 patients ill with psoriasis. Hebei J Tradit Chinese Med 4:20.
7. He R, Tan L, Browning DD, Wang JM, and Ye RD (2000) The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol 165:4598-4605.
8. Jian L, Zhang QC, and Ma HY (2003) Advances in the study of active components and pharmacological effects of Langdu. Northwest Pharm J 18:185-187.
9. Karin M, Yamamoto Y, and Wang QM (2004) The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3:17-26.
10. Karin M and Yinon BN (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18:621-663.
11. Le Y, Gong W, Li B, Dunlop NM, Shen W, Su SB, Ye RD, and Wang JM (1999) Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 163:6777-6784.
12. Lin X and Zhu JH (1992) An overview of the status of pharmacological studies and clinical applications of Langdu. Zhejiang J Tradit Chinese Med 7:331-333.
13. Lin Y-Z, Yao SY, Veach RA, Torgerson TR, and Hawiger J (1995) Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255-14258.
14. Liu GQ, Tatematsu H, Kurokawa M, Niwa M, and Hirata Y (1984) Novel C-3/C-3″-biflavanones from Stellera chamaejasme L. Chem Pharm Bull 32:362-365.
15. Liu WK, Ho JCK, Qin G, and Che CT (2002) Jolkinolide B induces neuroendocrine differentiation of human prostate LNCaP cancer cell line. Biochem Pharmacol 63:951-957.
16. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, et al. (1997) IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science (Wash DC) 278:860-866.
17. Nanamori M, Cheng XY, Mei JH, Sang HR, Xuan YX, Zhou CH, Wang MW, and Ye RD (2004) A novel nonpeptide ligand for formyl peptide receptor-like 1. Mol Pharmacol 66:1213-1222.
18. Niwa M, Chen XF, Liu GQ, and Tatematsu H (1984) Structure of isochamaejasmin from Stellera chamaejasme L. Chem Lett 13:1587-1590.
19. Niwa M, Otsuji S, Tatematsu H, and Liu GQ (1986) Stereostructures of two biflavanones from Stellera Chamaejasme L. Chem Pharm Bull 34:3249-3251.
20. Pei YH, Feng BM, Hua HM, Han B, and Wang T (2001) Advances in chemical and pharmacological studies on Stellera Chamaejasme. Chinese Tradit Herbal Drugs 32:764-766.
21. Philip M, Rowley DA, and Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14:433-439.
22. Perkins ND (2004) NF-κB: tumor promoter or suppressor? Trends Cell Biol 14:64-69.
23. Si ZH (1989) A brief introduction on the application of Langdu in skin diseases. Jilin J Tradit Chinese Med 4:36.
24. Sonenshein GE (1997) Rel/NF-κB transcription factors and the control of apoptosis. Semin Cancer Biol 8:113-119.
25. Stahelin RV, Digman MA, Medkova M, Ananthanarayanan B, Rafter JD, Melowic HR, and Cho W (2004) Mechanism of diacylglycerol-induced membrane targeting and activation of protein kinase C δ. J Biol Chem 279:29501-29512.
26. Su SB, Gong WH, Gao J-L, Shen WP, Murphy PM, Oppenheim JJ, and Wang JM (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189:395-402.
27. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, and Verma IM (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science (Wash DC) 274:787-789.
28. Xing YQ, Sun ZZ, Ma DS, and Chen G (1992) Comparative study on the total flavonoid constitution of Stella chamaejasme L. and Euphorbia fischeriana Steud. Mod Appl Pharm 9:60-63.
29. Yang BY and Lu FX (1989) Treatment of 54 cases of malignant tumors with Stellera chamaejasme L. J Combined Chinese Western Med 9:683-685.
30. Yang EB, Zhao YN, Zhang K, and Mack P (1999) Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem Biophys Res Commun 260:682-685.
31. Yang YQ (1956) Observations on the clinical efficacy of Langdu in patients with tuberculosis. J Tradit Chinese Med 7:365.
32. Yoshida M, Feng WJ, Saijo N, and Ikekawa T (1996) Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L. Int J Cancer 66:268-273.
33. Yoshida M, Yokokura H, Hidaka H, Ikekawa T, and Saijo N (1998) Mechanism of antitumor action of PKC activator, gnidimacrin. Int J Cancer 77:243-250.
34. Zhang MN, Liu YX, and Wang MZ (2000) Advances in the study of Stellera chamaejasme L. Shanxi Med J 29:213-215.
35. Zhou SM, Liu S, and Li KY (1997) Research progresses in the study of Langdu. J Anhui TCM College 16:59-62.